AMLX vs CLOV
Amylyx Pharmaceuticals Inc (AMLX) versus Clover Health Investments Corp (CLOV) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
AMLX currently screens at market cap $561.6M. CLOV currently screens at market cap $1.55B.
Not investment advice. Open the AMLX and CLOV stock pages for the full models.
Not investment advice.